Sufirtan en es it fr

Sufirtan Brand names, Sufirtan Analogs

Sufirtan Brand Names Mixture

  • No information avaliable

Sufirtan Chemical_Formula


Sufirtan RX_link

Sufirtan fda sheet

Sufirtan FDA

Sufirtan msds (material safety sheet)

Sufirtan MSDS

Sufirtan Synthesis Reference

No information avaliable

Sufirtan Molecular Weight

149.212 g/mol

Sufirtan Melting Point

198.5 oC

Sufirtan H2O Solubility

1.11E+005 mg/L

Sufirtan State


Sufirtan LogP


Sufirtan Dosage Forms

Capsule; Tablet

Sufirtan Indication

For treatment of Wilson's disease, cystinuria and active rheumatoid arthritis

Sufirtan Pharmacology

Penicillamine is a chelating agent used in the treatment of Wilson's disease. It is also used to reduce cystine excretion in cystinuria and to treat patients with severe, active rheumatoid arthritis unresponsive to conventional therapy. Penicillamine is used as a form of immunosuppression to treat rheumatoid arthritis. It works by reducing numbers of T-lymphocytes, inhibiting macrophage function, decreasing IL-1, decreasing rheumatoid factor, and preventing collagen from cross-linking. Its use in Wilson's disease, a rare genetic disorder of copper metabolism, relies on its binding to accumulated copper and elimination through urine.

Sufirtan Absorption

rapidly but incompletely

Sufirtan side effects and Toxicity

No information avaliable

Sufirtan Patient Information

No information avaliable

Sufirtan Organisms Affected

Humans and other mammals